Pharmacokinetics of viral antibodies after administration of intravenous immunoglobulin in patients with chronic lymphocytic leukaemia or multiple myeloma.

Thürmann, P A; Sonnenburg, C; Valentová, K; Gregora, E; Freischläger, F; Lissner, R

Thürmann, P A; Sonnenburg, C; Valentová, K; Gregora, E; Freischläger, F; Lissner, R.

Affiliation

Thürmann PA; University Witten/Herdecke, Hospital Wuppertal GmbH, Germany. petra.thuermann@klinikum-wuppertal.de

Eur J Clin Pharmacol ; 57(3): 235-41, 2001 Jun.

Article in En | MEDLINE | ID: mdl-11497339

Subject(s)

Antibodies, Viral/metabolism; Immunoglobulins, Intravenous; Leukemia, Lymphocytic, Chronic, B-Cell/metabolism; Multiple Myeloma/metabolism; Antibodies, Viral/blood; Area Under Curve; Cytomegalovirus/immunology; Female; Half-Life; Hepatitis B/immunology; Herpesvirus 3, Human/immunology; Humans; Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy; Leukemia, Lymphocytic, Chronic, B-Cell/radiotherapy; Male; Metabolic Clearance Rate; Middle Aged; Multiple Myeloma/drug therapy; Multiple Myeloma/radiotherapy; Pharmacokinetics

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Immunoglobulins, Intravenous / Antibodies, Viral / Multiple Myeloma Type of study: Guideline / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Eur J Clin Pharmacol Year: 2001 Document type: Article Affiliation country: Germany

Search on Google

Add to My VHL

XML

PubMed Links